Glucagon-Like Peptide-1 agonists in perioperative medicine: to suspend or not to suspend, that is the question.
作者信息
Mendes Florentino Fernandes, Carvalho Lorena Ibiapina M, Lopes Maristela Bueno
机构信息
Universidade Federal de Ciências da Saúde de Porto Alegre (UFCSPA), Departamento de Clínica Cirúrgica, Programa de Pós-Graduação em Tecnologia da Informação e Gestão em Saúde, Porto Alegre, RS, Brazil.
Hospital Prontomed, Teresina, PI, Brazil; Hospital Unimed Primavera, Departamento de Anestesiologia, Teresina, PI, Brazil.
出版信息
Braz J Anesthesiol. 2024 Nov-Dec;74(6):844538. doi: 10.1016/j.bjane.2024.844538. Epub 2024 Jun 27.
Abstract
摘要
相似文献
1
Glucagon-Like Peptide-1 agonists in perioperative medicine: to suspend or not to suspend, that is the question.胰高血糖素样肽-1激动剂在围手术期医学中的应用：停用还是不停用，这是个问题。
Braz J Anesthesiol. 2024 Nov-Dec;74(6):844538. doi: 10.1016/j.bjane.2024.844538. Epub 2024 Jun 27.
2
Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice.胰高血糖素样肽-1 受体激动剂：临床药理学的叙述性综述及其对围手术期实践的影响。
Anaesthesia. 2024 Jul;79(7):735-747. doi: 10.1111/anae.16306. Epub 2024 May 13.
3
The Impact of Glucagon-Like Peptide-1 Agonists on Hip and Knee Arthroplasty and Perioperative Considerations.胰高血糖素样肽-1 类似物对髋关节和膝关节置换术的影响及围手术期注意事项。
J Arthroplasty. 2024 Jun;39(6):1455-1458. doi: 10.1016/j.arth.2023.12.002. Epub 2023 Dec 8.
4
Perioperative use of glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter 2 inhibitors for diabetes mellitus.胰高血糖素样肽-1 受体激动剂和钠-葡萄糖共转运蛋白 2 抑制剂在糖尿病围手术期的应用。
Br J Anaesth. 2024 Apr;132(4):639-643. doi: 10.1016/j.bja.2023.12.015. Epub 2024 Jan 29.
5
Repositioning of dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 agonists as potential neuroprotective agents.将二肽基肽酶-4抑制剂和胰高血糖素样肽-1激动剂重新定位为潜在的神经保护剂。
Neural Regen Res. 2019 May;14(5):745-748. doi: 10.4103/1673-5374.249217.
6
Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists. Comment on Br J Anaesth 2024; 132: 644-8.长效胰高血糖素样肽-1（GLP-1）受体激动剂的围手术期管理。对《英国麻醉学杂志》2024年；132: 644 - 8的评论
Br J Anaesth. 2024 Oct;133(4):884-886. doi: 10.1016/j.bja.2024.05.043. Epub 2024 Jul 25.
7
Effect of glucagon-like peptide-1 receptor agonists in subjects with type 2 diabetes mellitus: A meta-analysis.胰高血糖素样肽-1 受体激动剂在 2 型糖尿病患者中的作用：一项荟萃分析。
J Clin Pharm Ther. 2021 Dec;46(6):1650-1658. doi: 10.1111/jcpt.13502. Epub 2021 Aug 5.
8
Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration.长效胰高血糖素样肽-1（GLP-1）受体激动剂的围手术期管理：关注胃排空延迟和肺吸入的问题。
Br J Anaesth. 2024 Apr;132(4):644-648. doi: 10.1016/j.bja.2024.01.001. Epub 2024 Jan 29.
9
Incretin-based therapies for type 2 diabetes mellitus: a review of direct comparisons of efficacy, safety and patient satisfaction.基于肠降血糖素的 2 型糖尿病治疗药物：对疗效、安全性和患者满意度的直接比较的综述。
Int J Clin Pharm. 2013 Apr;35(2):159-72. doi: 10.1007/s11096-012-9729-9. Epub 2012 Dec 22.
10
Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations.比较胰高血糖素样肽-1 受体激动剂围手术期管理的社会指导：对临床实践和未来研究的影响。
Can J Anaesth. 2024 Sep;71(9):1302-1315. doi: 10.1007/s12630-024-02810-5. Epub 2024 Aug 26.
引用本文的文献
1
The role of GLP-1 agonists in perioperative care: a suspension dilemma.胰高血糖素样肽-1激动剂在围手术期护理中的作用：一个悬而未决的难题。
Braz J Anesthesiol. 2025 Aug 5;75(5):844668. doi: 10.1016/j.bjane.2025.844668.
2
Glucagon-like Peptide-1 Receptor Agonist Therapy Is Associated With Fewer Medical Complications After Carpal Tunnel Release in Diabetic Patients.胰高血糖素样肽-1受体激动剂治疗与糖尿病患者腕管松解术后较少的医学并发症相关。
Hand (N Y). 2025 Jul 16:15589447251350181. doi: 10.1177/15589447251350181.
3
Comparing the risk of gastroparesis following different modalities for treating obesity: semaglutide versus bupropion-naltrexone versus sleeve gastrectomy - a retrospective cohort study.比较不同肥胖治疗方式后发生胃轻瘫的风险：司美格鲁肽与安非他酮-纳曲酮与袖状胃切除术——一项回顾性队列研究。
BMJ Open Gastroenterol. 2025 Apr 2;12(1):e001704. doi: 10.1136/bmjgast-2024-001704.
Zotero 插件